Virtu Financial’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18K | Buy |
+24,865
| New | +$18K | ﹤0.01% | 1262 |
|
|
2024
Q2 | – | Sell |
-39,167
| Closed | -$94K | – | 1372 |
|
|
2024
Q1 | $94K | Buy |
+39,167
| New | +$94K | 0.01% | 929 |
|
|
2023
Q3 | – | Sell |
-39,021
| Closed | -$167K | – | 1374 |
|
|
2023
Q2 | $167K | Buy |
+39,021
| New | +$167K | 0.01% | 868 |
|
|
2018
Q3 | – | Sell |
-10,414
| Closed | -$146K | – | 1590 |
|
|
2018
Q2 | $146K | Sell |
10,414
-6,972
| -40% | -$97.7K | 0.01% | 1577 |
|
|
2018
Q1 | $192K | Buy |
+17,386
| New | +$192K | 0.01% | 1378 |
|